Literature DB >> 24152481

Palliative sedation in Dutch general practice from 2005 to 2011: a dynamic cohort study of trends and reasons.

Gé A Donker1, Frank G Slotman, Peter Spreeuwenberg, Anneke L Francke.   

Abstract

BACKGROUND: Little is known about the quantity and reasons for use of palliative sedation in general practice. AIM: To gain more insight into the trends of and reasons for palliative sedation in Dutch general practice. DESIGN AND
SETTING: Dynamic cohort study using registrations and questionnaire data of Dutch GPs. Method Data collected in the years from 2005 until 2011 in the Dutch Sentinel General Practice Network were analysed. Trends and reasons for use of palliative sedation were analysed using multilevel analyses to control for clustering of observations within general practices.
RESULTS: From 2005-2011, 183 cases were reported from 56 general practices. The incidence of palliative sedation fluctuated between 33.7 per 100 000 patients in 2006 and 15.2 in 2011. No rise or decline during the period was observed. Palliative sedation was applied in 5.7% of all deaths and most frequently used in younger patients with cancer. The mean number of refractory symptoms was 2.6 (SD 1.2); pain (69.4%), dyspnoea (53.0%), and fear (39.3%). Patient involvement in decision making before the start of palliative sedation (87.4%) was less frequently present in patients suffering from cardiovascular or chronic obstructive pulmonary disease and in older patients compared to patients with cancer (P<0.05). Pending euthanasia requests were present in 20.8% of cases; the choice for palliative sedation in these cases was clearly motivated.
CONCLUSION: Palliative sedation is performed in a small proportion of dying patients in Dutch general practice, without a rise or decline observed from 2005 to 2011. Patients with non-cancer diseases are less frequently involved in decision making than patients with cancer, possibly related to sudden deterioration.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24152481      PMCID: PMC3782799          DOI: 10.3399/bjgp13X673676

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  22 in total

1.  Sedative use in the last week of life and the implications for end-of-life decision making.

Authors:  Nigel Sykes; Andrew Thorns
Journal:  Arch Intern Med       Date:  2003-02-10

2.  [Fourth evaluation of the law on the review of termination of life on request and assisted suicide (Euthanasia Act)].

Authors:  A van der Heide; B D Onwuteaka-Philipsen; J J M van Delden; J K M Gevers; P J van der Maas; G van der Wal
Journal:  Ned Tijdschr Geneeskd       Date:  2005-09-24

3.  End-of-life practices in the Netherlands under the Euthanasia Act.

Authors:  Agnes van der Heide; Bregje D Onwuteaka-Philipsen; Mette L Rurup; Hilde M Buiting; Johannes J M van Delden; Johanna E Hanssen-de Wolf; Anke G J M Janssen; H Roeline W Pasman; Judith A C Rietjens; Cornelis J M Prins; Ingeborg M Deerenberg; Joseph K M Gevers; Paul J van der Maas; Gerrit van der Wal
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245

Review 4.  Palliative sedation: a review of the research literature.

Authors:  Patricia Claessens; Johan Menten; Paul Schotsmans; Bert Broeckaert
Journal:  J Pain Symptom Manage       Date:  2008-07-25       Impact factor: 3.612

5.  Responders and non-responders in a study on medical end-of-life decisions in Denmark, the Netherlands, Sweden and Switzerland.

Authors:  Susanne Fischer; Guido Miccinesi; Rainer Hornung; Georg Bosshard; Luc Deliens; Agnes van der Heide; Tore Nilstun; Michael Norup; Bregje D Onwuteaka-Philipsen
Journal:  Soz Praventivmed       Date:  2006

6.  Preferences of the Dutch general public for a good death and associations with attitudes towards end-of-life decision-making.

Authors:  Judith A C Rietjens; Agnes van der Heide; Bregje D Onwuteaka-Philipsen; Paul J van der Maas; Gerrit van der Wal
Journal:  Palliat Med       Date:  2006-10       Impact factor: 4.762

7.  Continuous deep sedation: physicians' experiences in six European countries.

Authors:  Guido Miccinesi; Judith A C Rietjens; Luc Deliens; Eugenio Paci; Georg Bosshard; Tore Nilstun; Michael Norup; Gerrit van der Wal
Journal:  J Pain Symptom Manage       Date:  2006-02       Impact factor: 3.612

8.  Dealing with delicate issues in continuous deep sedation. Varying practices among Dutch medical specialists, general practitioners, and nursing home physicians.

Authors:  Jeroen G J Hasselaar; Rob P B Reuzel; Maria E T C van den Muijsenbergh; Raymond T C M Koopmans; Carlo J W Leget; Ben J P Crul; Kris C P Vissers
Journal:  Arch Intern Med       Date:  2008-03-10

9.  Palliative sedation in a specialized unit for acute palliative care in a cancer hospital: comparing patients dying with and without palliative sedation.

Authors:  Judith A C Rietjens; Lia van Zuylen; Hetty van Veluw; Lidemarie van der Wijk; Agnes van der Heide; Carin C D van der Rijt
Journal:  J Pain Symptom Manage       Date:  2008-04-14       Impact factor: 3.612

10.  Pressure during decision making of continuous sedation in end-of-life situations in Dutch general practice.

Authors:  Marco H Blanker; Marlies Koerhuis-Roessink; Siebe J Swart; Wouter W A Zuurmond; Agnes van der Heide; Roberto S G M Perez; Judith A C Rietjens
Journal:  BMC Fam Pract       Date:  2012-07-03       Impact factor: 2.497

View more
  3 in total

1.  Never the right time: advance care planning with frail and older people.

Authors:  Theresa Eynon; Mayur K Lakhani; Richard Baker
Journal:  Br J Gen Pract       Date:  2013-10       Impact factor: 5.386

2.  Palliative care for patients with cancer: do patients receive the care they consider important? A survey study.

Authors:  Marianne Heins; Jolien Hofstede; Mieke Rijken; Joke Korevaar; Gé Donker; Anneke Francke
Journal:  BMC Palliat Care       Date:  2018-04-17       Impact factor: 3.234

3.  Addressing Palliative Sedation during Expert Consultation: A Descriptive Analysis of the Practice of Dutch Palliative Care Consultation Teams.

Authors:  Patrick Hoek; Ilse Grandjean; Constans A H H V M Verhagen; Marlies L E A Jansen-Landheer; Henk J Schers; Cilia Galesloot; Kris C P Vissers; Yvonne Engels; Jeroen G J Hasselaar
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.